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Chk1 kinase, a DNA damage/replication G2 checkpoint kinase, has recently been shown to phosphorylate and inhibit
Cdc25C, a Cdc2 Tyr-15 phosphatase, thereby directly linking the G2 checkpoint to negative regulation of Cdc2. Immature
Xenopus oocytes are arrested naturally at the first meiotic prophase (prophase I) or the late G2 phase, with sustained Cdc2
yr-15 phosphorylation. Here we have cloned a Xenopus homolog of Chk1, determined its developmental expression, and
examined its possible role in prophase I arrest of oocytes. Xenopus Chk1 protein is expressed at approximately constant
levels throughout oocyte maturation and early embryogenesis. Overexpression of wild-type Chk1 in oocytes prevents the
release from prophase I arrest by progesterone. Conversely, specific inhibition of endogenous Chk1 either by overexpression
of a dominant-negative Chk1 mutant or by injection of a neutralizing anti-Chk1 antibody facilitates prophase I release by
progesterone. Moreover, when ectopically expressed in oocytes, a Chk1-nonphosphorylatable Cdc25C mutant alone can
induce prophase I release much more efficiently than wild-type Cdc25C; if endogenous Chk1 function is inhibited, however,
even wild-type Cdc25C can induce the release very efficiently. These results suggest strongly that Chk1 is involved in
physiological prophase I arrest of Xenopus oocytes via the direct phosphorylation and inhibition of Cdc25C. We discuss the
ossibility that Chk1 might function either as a G2 checkpoint kinase or as an ordinary cell cycle regulator in
rophase-I-arrested oocytes. © 1999 Academic Press


















The mitotic cell cycle in all eukaryotic cells consists of
two alternating S and M phases and intervening G1 and G2
phases (Murray and Hunt, 1993). The G1/S and G2/M
transitions are crucial points for the progression of the cell
cycle, which is controlled by cyclin-dependent protein
kinases (Cdks) (Norbury and Nurse, 1992; Morgan, 1995;
Nigg, 1995). The progression through M phase is controlled
by maturation/M phase-promoting factor MPF, which is a
complex of Cdc2 (or Cdk1) kinase and cyclin B (Masui and
Markert, 1971; Nurse, 1990). MPF undergoes tight regula-
tion during the G2/M transition by phosphorylation and
dephosphorylation of Cdc2. In the G2 phase of vertebrate
cells, Cdc2 is kept inactivated by inhibitory phosphoryla-
tions on tyrosine 15 (Tyr-15) and threonine 14 (Thr-14);
these phosphorylations are catalyzed by Wee1/Myt1 ki-
nases (Coleman and Dunphy, 1994; Mueller et al., 1995a).1 To whom correspondence should be addressed. Fax: 81-92-642-
2645. E-mail: nsagascb@mbox.nc.kyushu-u.ac.jp.
432n entry into M phase, Cdc25C, a dual-specificity phospha-
ase, dephosphorylates Cdc2 on both Tyr-15 and Thr-14,
ausing the activation of MPF (Strausfeld et al., 1991; Millar
nd Russell, 1992). Thus, in principle, the G2/M transition
an be induced by inactivation of Wee1/Myt1 kinases or
ctivation of Cdc25C phosphatase or both (Dunphy, 1994;
ing et al., 1994).
The dependence of cell cycle progression on the integrity
f the genome has been described as checkpoint control
Hartwell and Weinert, 1989). In both Schizosaccharomyces
ombe and mammalian cells, DNA damage induced by
amma irradiation or ultraviolet light activates the G2
heckpoint, which arrests the cells in G2 phase until DNA
amage is repaired (Carr and Hoekstra, 1995; D’Urso and
urse, 1995). Unlike the previous speculation (Barbet and
arr, 1993), this G2 checkpoint arrest is now known to
equire inhibitory Tyr-15 phosphorylation of Cdc2 (Rhind
t al., 1997; O’Connell et al., 1997). Many gene products,
including Rad3, Chk1, and Rad24/25, are involved in the
DNA damage G2 checkpoint pathway (reviewed by Shel-
drick and Carr, 1993; Murray, 1994). Chk1 (checkpoint 1
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433Chk1 Kinase in Xenopus Oocyteskinase), which is probably activated by the upstream kinase
Rad3 (or ATM/ATR proteins in humans), is an evolution-
arily well-conserved protein kinase (Walworth et al., 1993;
Fogarty et al., 1997; Sanchez et al., 1997) and is also likely
o be involved in the DNA replication G2 checkpoint
Francesconi et al., 1997; Peng et al., 1997), which is
nduced by unreplicated DNA and arrests cells in G2 phase
ntil DNA replication is completed (Sheldrick and Carr,
993; D’Urso and Nurse, 1995). Chk1 has recently been
hown to bind to and require Cdc25 for it to function in S.
ombe (Furnari et al., 1997) and has been shown to directly
hosphorylate Cdc25C on Ser-216 and inhibit its function
n human cells (Peng et al., 1997; Sanchez et al., 1997). The
nhibition of Cdc25C by Chk1 is mediated by the binding of
4-3-3 proteins (or Rad24/25 in S. pombe) to the Chk1
hosphorylation site (Peng et al., 1997); this binding seems
o inhibit the activation, but not the catalytic activity, of
dc25C, presumably via a sequestration mechanism (cf.
urse, 1997). It has thus been thought that Chk1 kinase,
nce activated by the DNA damage/replication G2 check-
oint, directly downregulates Cdc25C function, thereby
reventing Cdc2 Tyr-15 dephosphorylation (and hence de-
aying mitosis) until DNA repair/replication is completed
Weinert, 1997; Nurse, 1997).
Despite the established role of Chk1 in G2 checkpoint
ontrol in yeast and mammalian tissue culture cells, its
hysiological role(s) in normal metazoan development is
argely unknown. Recently, however, a few studies have
uggested that Chk1 may play an important role in a
pecific cell type(s) or stage(s) during normal development.
hus, in mice, Chk1 protein has been shown to localize to
eiotic chromosomes in late zygotene and pachytene sper-
atocytes (Flaggs et al., 1997); although not proved, this
ocalization might well represent Chk1 function as a DNA
amage checkpoint kinase, since, in the zygotene/
achytene stages of meiosis I, DNA double-strand breaks
and hence “damage”) occur naturally for meiotic recombi-
ation (see Hawley and Arbel, 1993; Lydall et al., 1996). In
rosophila development, on the other hand, the grapes
ene product (the Drosophila homolog of Chk1) has been
hown to be required for the elongation of the cell cycle that
ccurs at the midblastula stage (Fogarty et al., 1997; Sibon
t al., 1997); Chk1 function at this stage of development has
een proposed to mediate the DNA replication checkpoint
Sibon et al., 1997), which is thought to be activated, at this
tage, due to the exponentially increased nucleocytoplas-
ic ratio (Newport and Kirschner, 1982; Edgar et al., 1986;
asso and Newport, 1990). In neither of these two cases,
owever, have the precise function(s) and the direct target(s)
f Chk1 been known, although in the latter case, Chk1
ight induce downregulation (or degradation) of String
Sibon et al., 1997), the Drosophila homolog of Cdc25
Edgar and O’Farrell, 1989).
Another potential cell type or developmental stage in
hich Chk1 might play an important physiological role ishe oocyte (stage). Indeed, immature oocytes of all animal
pecies are arrested naturally at the first meiotic prophase
G
(
Copyright © 1999 by Academic Press. All rightr prophase I, which corresponds to the late G2 phase
Murray and Hunt, 1993; Sagata, 1996). This arrest is
eleased usually by either fertilization or hormonal stimuli,
epending on the species, and the oocytes resume meiosis
ia a cellular process called maturation (Masui and Clarke,
979). Many factors, including protein kinase A (Maller and
rebs, 1977; Bornslaeger et al., 1986) and protein phospha-
ase 2A (Mumby and Walter, 1993; Lee et al., 1994), seem to
e involved in this universal arrest of immature oocytes.
rom the aspect of meiotic progression, however, immature
ocytes are cells that have completed DNA replication and
eiotic recombination long before their arrest at prophase I
or, more strictly, at the diplotene stage) (Benbow, 1985;
agata, 1996), and they have an extremely low
ucleus(DNA)–cytoplasm ratio (Schuetz, 1985). Formally,
herefore, the ordinary DNA damage/replication G2 check-
oint controls might not operate for prophase I arrest of
ocytes (cf. Newport and Dasso, 1989; Dasso and Newport,
990). However, prophase I (or G2) arrest of immature
ocytes is generally associated with Cdc2 Tyr-15 phosphor-
lation in many species (Ferrell et al., 1991; Ookata et al.,
992; Gavin et al., 1994) and hence might involve some
ype of G2 checkpoint control (cf. Murray and Hunt, 1993;
hind et al., 1997). Thus, it will be of great interest to see
hether Chk1, a G2 checkpoint kinase, plays any role in
rophase I arrest of oocytes.
In the present study, we have cloned a Xenopus homolog
f Chk1, determined its developmental expression, and
xamined its possible role in prophase I arrest of immature
ocytes. We show that inhibition of endogenous Chk1
unction either by overexpression of a dominant-negative
hk1 mutant or by injection of a neutralizing anti-Chk1
ntibody facilitates the release of oocytes from prophase I
rrest, while overexpression of wild-type Chk1 prevents it.
oreover, by using a Chk1-nonphosphorylatable Cdc25C
utant, we show strong evidence that Chk1 directly and
onstitutively acts on and inhibits Cdc25C in immature
ocytes. These results show, for the first time, that the
hk1/Cdc25C pathway plays a significant role in physio-
ogical prophase I arrest of oocytes. The function of Chk1 in
mmature oocytes is discussed in relation to (possible) G2




To clone a cDNA encoding the Xenopus homolog of Chk1
kinase, PCR was first performed against a Xenopus oocyte cDNA
library in lgt10 (Rebagliati et al., 1985), by using degenerate
ligonucleotide primers. The degenerate primers were derived from
inase domains V and IX (Hanks and Hunter, 1995) of S. pombe
Walworth et al., 1993), human (Sanchez et al., 1997), and Drosoph-
la Chk1 kinases (Fogarty et al., 1997) and were 59-GGIGGIGA
A/G)(C/T)TITT(C/T)GA(C/T)(A/C)G(A/G/C/T)AT(A/T/C)GA(A/
)CC-39 (where I is inosine) for the 59 primer and 59-A
A/G)IA(C/T)IA(C/T)ICC(A/G)CAI(C/G)(A/T)CCA(A/G/C/T)AC





























434 Nakajo et al.(A/G)TC-39 for the 39 primer. The 0.3-kb PCR product obtained was
ubcloned into pGEM-T Easy (Promega), sequenced, and found to
ncode a partial sequence of Xenopus Chk1. The partial cDNA was
hen used as a plaque hybridization probe, to clone a cDNA
ncoding full-length Chk1 protein from the oocyte cDNA library.
fter screening of 3 3 105 independent phages, 19 positive clones
were obtained, and after sequencing, the longest cDNA (a 1.5-kb
EcoRI fragment) was subcloned into pT7G(UK 1), a pIBIDSph
derivative of the pSP64T plasmid vector (Krieg and Melton, 1984;
Furuno et al., 1994).
Construction of Recombinant Plasmids
A kinase-deficient, full-length XeChk1 mutant (termed DA-
Chk) was made by Asp-148 3 Ala mutagenesis of wild-type
XeChk1, by using the Quick Change Site-Directed Mutagenesis Kit
(Strategene); the primer used for this mutagenesis was 59-
CAGCTGAAAATCTCTGCCTTTGGTTTAGCAACG-39 (in the
sense strand). A Ser-287 3 Ala Cdc25C mutant (SA-Cdc25) was
prepared similarly from wild-type Xenopus Cdc25C (Izumi et al.,
992; Okazaki et al., 1996), by using 59-CGCCTTTAC-
GCTCGCCGGCCATGCCAGAGAAGCTT-39 as a primer (in
he sense strand). A cDNA encoding an N-terminal one-third
amino acids 1–148) of XeChk1 (DC-Chk) was prepared by PCR
f wild-type XeChk1, by the use of the following primers:
9-GCTCTAGAACCATGGCAGTTCCGTTTGTTGAAG-39 as a
59 primer and 59-CGGGATCCCTAGTCAGAGATTTTCAGC-
TGA-39 as a 39 primer. Another cDNA encoding a C-terminal half
(amino acids 264–472) of wild-type XeChk1 (DN-Chk) was pre-
pared by PCR of wild-type XeChk1, by the use of 59-
GCTCTAGAACCATGACAGAAATAATCAAAAAAGGAC-39 as
a 59 primer and 59-CGGGATCCTCAAGTGGCAGACAGAA-
CTTTTTG-39 as a 39 primer. The PCR products as well as the
mutants with site-directed mutagenesis were digested with appro-
priate restriction enzymes and subcloned into either pT7G(UK1)
(for DA-Chk, DC-Chk, and DN-Chk) or pIBIDSph (for WT-Cdc25
and SA-Cdc25).
In Vitro Transcription
All the constructs in pT7G(UK1) or pIBIDSph were cut singly
with NotI and in vitro transcribed into 59-capped mRNAs by using
the MEGA Script T7 Kit (Ambion); the in vitro synthesized mRNA
was dissolved in distilled water.
Antibodies and Western Blot Analysis
Polyclonal antibodies were raised in rabbits against bacterially
produced proteins from Xenopus Chk1 (this paper) and Cdc25C
cDNAs (Izumi et al., 1992; Okazaki et al., 1996) by standard
ethods and then affinity-purified by using Affi-gel 15 (Bio-Rad).
nti-phospho Cdc2(Y15) antibody was from New England Biolabs.
ocyte or embryo extracts, equivalent to one oocyte or embryo and
repared in EB buffer (Gerhart et al., 1984), were subjected to
estern blot analysis with anti-XeChk1 antibody (1 mg/ml), anti-
dc25C antibody (0.5 mg/ml), or anti-phospho Cdc2(Y15) antibody
1:500), essentially as described previously (Furuno et al., 1994). As
a secondary antibody, a donkey anti-rabbit IgG antibody (conju-
gated to horseradish peroxidase) (1:1000; Amersham) was used and
detected by either the ECL system (Amersham) or the Super Signal
ULTRA Chemiluminescent Substrate system (Pierce).
Copyright © 1999 by Academic Press. All rightPreparation, Culture, and Microinjection of
Oocytes and Embryos
Stage VI oocytes (Dumont, 1972) were prepared in modified
Barth’s solution (MBS) as described (Sagata et al., 1988) and
cultured at 20–22°C in 50% Leiboviz-15 medium (Sigma). Oocyte
maturation was induced by the addition of progesterone (5 mg /ml)
o the culture medium. Ovulated eggs were in vitro fertilized, and
mbryos were staged according to Nieuwkoop and Faber (1956).
icroinjection of mRNA or antibodies into the oocyte was per-
ormed by using Nanoject (Drummond Scientific Co.).
RESULTS
cDNA Cloning of a Xenopus Homolog of Chk1
cDNAs encoding a Xenopus homolog of Chk1 were
cloned by a PCR-based strategy from a Xenopus ovarian
DNA library (see Materials and Methods). Sequence anal-
sis of the longest cDNA revealed that it contained an open
eading frame capable of encoding 472 amino acid residues
Fig. 1A). The deduced amino acid sequence was 77, 43, and
8% identical to those of human (Sanchez et al., 1997),
rosophila (Fogarty et al., 1997), and S. pombe Chk1
kinases (Walworth et al., 1993), respectively (Fig. 1B). Its
very strong similarity to human Chk1 throughout the
entire sequence indicates that the clone most probably
corresponds to the Xenopus homolog of Chk1 (and hence it
is designated XeChk1). The sequence comparison also re-
veals that XeChk1 has significantly stronger similarity in
the N-terminal half (or the catalytic domain; cf. Sanchez et
al., 1997; see also Fig. 1A) than in the C-terminal half to
Chk1 kinases of other species. The C-terminal half, how-
ever, has several short stretches of amino acids that are well
conserved (Fig. 1B) and may be a regulatory domain (see
later).
Developmental Expression of XeChk1
To examine the developmental expression pattern of
XeChk1 protein, we performed Western blot analysis of
oocytes and embryos, using anti-XeChk1 antibody that was
raised in a rabbit against bacterially produced XeChk1
protein and then affinity-purified (see Materials and Meth-
ods). In prophase-I-arrested immature oocytes, a protein
with a molecular mass of 53 kDa was clearly detected (Fig.
2A); this protein comigrated with exogenously synthesized
(or overexpressed) XeChk1 protein (Fig. 2A, first lane) and
was also detected with another, independently raised anti-
XeChk1 antibody (not shown), consistent with it being
XeChk1 protein. After treatment of immature oocytes with
progesterone (to induce meiotic maturation), essentially the
same levels of XeChk1 were detected in oocytes undergoing
germinal vesicle breakdown (GVBD; a hallmark for release
from prophase I arrest) and in mature oocytes arrested at the
second meiotic metaphase (metaphase II), indicating no
gross changes in the level of Chk1 expression during oocyte
maturation (Fig. 2A). Moreover, after fertilization of mature
s of reproduction in any form reserved.
usin
435Chk1 Kinase in Xenopus Oocytesoocytes (or ovulated eggs), XeChk1 was readily detected
through the cleavage, blastula, gastrula, and neurula stages,
again at approximately the same levels (Fig. 2B). Thus, these
FIG. 1. Sequence analysis of Xenopus Chk1 (XeChk1). (A) Nucleo
domain is boxed. Positions of mutagenesis (circled D or Asp, chan
used in the present study are indicated. The nucleotide sequen
Accession No. AB019218. (B) Alignment of the deduced amino acid
Drosophila (Dm; Fogarty et al., 1997), and S. pombe (Sp; Walworth
XeChk1 are in black boxes. Sequence alignment was performed byresults suggest that Chk1 kinase might play a role in
oocytes and early embryos of Xenopus. For comparison, we
Copyright © 1999 by Academic Press. All rightalso analyzed Cdc25C protein, a potential substrate for
XeChk1 (cf. Furnari et al., 1997; Sanchez et al., 1997), and
found that it was also expressed throughout oocyte matu-
nd deduced amino acid sequences of a XeChk1 cDNA. The kinase
o A or Ala for DA-Chk) and other mutants (DC-Chk and DN-Chk)
s been submitted to the GenBank/EMBL/DDBJ database under
nce of XeChk1 (X1) with those of human (Hs; Sanchez et al., 1997),
l., 1993) Chk1 kinases. Amino acid residues identical to those of




et aration and early embryogenesis, essentially as reported
previously (cf. Izumi et al., 1992; Hartley et al., 1996).












436 Nakajo et al.The Chk1/Cdc25C Pathway Can Operate
in Oocytes
In an effort toward understanding the role of XeChk1 in
prophase I (or G2) arrest of immature oocytes, first we
tested whether the Chk1 pathway could operate in Xenopus
oocytes. For this purpose, we injected immature oocytes
with mRNA (10 ng/oocyte) encoding either a kinase-
deficient, N-terminal one-third (amino acids 1–148) of Xe-
Chk1 (termed DC-Chk; see Fig. 1A) or wild-type XeChk1
(WT-Chk). Upon progesterone treatment, uninjected con-
trol oocytes and those injected with DC-Chk mRNA under-
went GVBD essentially with the same kinetics, 50% GVBD
occurring about 3 h after the hormonal treatment (Fig. 3A);
this result indicates that injection of DC-Chk mRNA has
essentially no effects on the meiotic maturation of oocytes
and can be used as a good control for mRNA injection. By
contrast, GVBD in oocytes injected with WT-Chk mRNA
was strongly inhibited or retarded, with only 25% GVBD
occurring as late as 8 h after the hormonal treatment (Fig.
3A). In these experiments, DC-Chk and WT-Chk proteins
FIG. 2. Developmental expression of XeChk1. (A) Expression of
XeChk1 during oocyte maturation. Immature oocytes (IMO) were
treated with progesterone (at time 0) to induce maturation and
sampled at the indicated times (in h) for Western blot analysis with
anti-XeChk1 antibody. Germinal vesicle breakdown (GVBD) and
metaphase II arrest of mature oocytes occurred at 3 and 7 h,
respectively, after progesterone treatment. The first lane (M) shows
an immature oocyte that was injected with XeChk1 mRNA (10 ng)
and cultured for 10 h. (B) Expression of XeChk1 during embryogen-
esis. Ovulated eggs were fertilized (at time 0), collected at the
indicated times (in h), and analyzed as above. An unfertilized egg
(UFE) and embryos at the morula (Mo.), blastula (Blas.), gastrula
(Gast.), and neurula (Neu.) stages are shown with Nieuwkoop and
Faber stages. The first lane (M) shows a fertilized egg that was
injected with XeChk1 mRNA (10 ng) and cultured for 6 h. Proteins
equivalent to one oocyte (A) or one egg or embryo (B) were
analyzed.were expressed in oocytes at comparable levels and in about
10-fold excess over endogenous XeChk1 (cf. Fig. 2A). Thus,
Copyright © 1999 by Academic Press. All rightverexpressed wild-type XeChk1, but not a kinase-deficient
-terminal fragment of XeChk1, had an activity to prevent
aturation of (G2-arrested) immature oocytes, as might be
xpected for Chk1 as a G2 checkpoint kinase. These results
uggest that (exogenous) Chk1 can function in oocytes,
resumably acting on a physiological substrate(s) that is
resent in oocytes.
FIG. 3. The Chk1/Cdc25C pathway can operate in Xenopus
ocytes. (A) Inhibition of progesterone-induced oocyte maturation
y overexpression of XeChk1. Thirty immature oocytes were
ninjected (None; E) or injected with mRNA (10 ng/oocyte) encod-
ng either wild-type XeChk1 (WT-Chk; F) or an N-terminal one-
third of XeChk1 (DC-Chk; ); 12 h later, they were treated with
progesterone (PG) to induce maturation and then scored for the
percentage GVBD at the indicated times. Results essentially simi-
lar to those presented here were obtained in three other indepen-
dent experiments. (B) Induction of maturation (or GVBD) by
overexpression of a Chk1-nonphosphorylatable Cdc25C mutant in
oocytes that were preloaded with WT-Chk. Thirty immature
oocytes were injected with WT-Chk mRNA (10 ng/oocyte); 12 h
later, they were reinjected with mRNA (5 ng/oocyte) encoding
either wild-type Cdc25C (WT-Cdc25; F) or a Chk1-
nonphosphorylatable Cdc25C mutant (SA-Cdc25; E), cultured, and
scored for the percentage GVBD. Results presented here were very
reproducible in four other independent experiments.



























437Chk1 Kinase in Xenopus OocytesWe then tested whether Chk1 can directly act on and
inhibit Cdc25C (a potential substrate for XeChk1) in oo-
cytes. Xenopus Cdc25C has a serine residue at position 287
Ser-287) (Izumi et al., 1992), which corresponds to Ser-216
of human Cdc25C (Kumagai et al., 1998a), a residue phos-
phorylated by human Chk1 (Sanchez et al., 1997). We
herefore injected immature oocytes first with WT-Chk
RNA (10 ng/oocyte) as above and then with mRNA (5
g/oocyte) encoding either wild-type Cdc25C (WT-Cdc25)
r a Chk1-nonphosphorylatable Ser-2873 Ala Cdc25C mu-
ant (SA-Cdc25) (SA-Cdc25, but not WT-Cdc25, was ex-
ected to escape inhibition by the overexpressed WT-Chk
ue to the nonphosphorylatable mutation). None of the
ocytes injected with WT-Cdc25 mRNA were able to
ndergo GVBD for at least 7–8 h after the injection (Fig. 3B).
Normally, high overexpression of wild-type Cdc25C alone
an induce GVBD fairly efficiently by directly Tyr-15-
ephosphorylating and activating Cdc2 (Lee et al., 1992;
offmann et al., 1993; see below).] By contrast, 100% of the
ocytes injected with SA-Cdc25 mRNA underwent GVBD
ery rapidly or within 4 h after the injection (Fig. 3B). In
hese experiments, WT-Cdc25 and SA-Cdc25 proteins were
roduced in oocytes in comparable amounts and in several-
old excess over endogenous Cdc25C. Thus, at least under
hese conditions, the Chk1-nonphosphorylatable Cdc25C
utant, but not wild-type Cdc25C, was able to override the
maturation-inhibiting) effect of overexpressed WT-Chk.
hese results suggest strongly that Chk1 can directly phos-
horylate Cdc25C on Ser-287 and can inhibit its function in
ocytes. Taken together, the present results indicate that
he Chk1/Cdc25C pathway can operate in Xenopus oo-
ytes.
Involvement of Chk1 in Prophase I Arrest
of Oocytes
Prophase I arrest of immature Xenopus oocytes is accom-
panied by Tyr-15 (and Thr-14) phosphorylation of Cdc2
kinase (Gautier and Maller, 1991; Ferrell et al., 1991),
raising the possibility that the arrest might be caused by
some G2 checkpoint control (cf. Rhind et al., 1997;
O’Connell et al., 1997). In fact, the presence of Chk1 in
oocytes (Fig. 2A) and the ability of overexpressed Chk1 to
inhibit maturation (or release from prophase I arrest ) (Fig.
3A) suggest that (endogenous) Chk1 might be involved in
prophase I arrest of oocytes. To test this intriguing possi-
bility, first we injected oocytes with mRNA (10 ng/oocyte)
encoding either control DC-Chk or a kinase-deficient, full-
length Asp-148 3 Ala Chk1 mutant (termed DA-Chk). [By
coexpression with wild-type Chk, DA-Chk turned out to be
a dominant-negative mutant, as are kinase-deficient mu-
tants of many other protein kinases (cf. Furuno et al.,
1994).] By injection alone, none of the oocytes showed any
appreciable sign of maturation (this was also the case with
injection of even higher doses of mRNA). Interestingly,
however, upon progesterone treatment, the oocytes injected
with DA-Chk mRNA underwent GVBD significantly (or
Copyright © 1999 by Academic Press. All right30–45 min) earlier than those injected with control DC-
Chk mRNA as well as uninjected control oocytes, with
50% GVBD occurring 2–2.5 h after the hormonal treatment
(Fig. 4A). Moreover, Western blot analysis with anti-
phospho-Tyr-15 antibody revealed that dephosphorylation
of Cdc2 Tyr-15 occurred similarly earlier in DA-Chk
FIG. 4. Involvement of Chk1 in prophase I arrest of immature
oocytes. (A) Effect of overexpression of a kinase-deficient XeChk1
mutant on release from prophase I arrest in progesterone-treated
oocytes. Thirty immature oocytes were uninjected (None; E) or
injected with mRNA (10 ng/oocyte) encoding either a control
XeChk1 mutant (DC-Chk; ) or a dominant-negative, kinase-
deficient full-length XeChk1 mutant (DA-Chk; F). Twelve hours
later, they were treated with progesterone (PG), cultured, and
scored for the percentage GVBD at the indicated times. (B) Effect of
injection of a neutralizing anti-XeChk1 antibody on release from
prophase I arrest in progesterone-treated oocytes. Thirty immature
oocytes were uninjected (None; E) or injected with either preim-
mune control antibody (IgG; ) or anti-XeChk1 antibody (a-Chk1;
F) (each 200 ng/oocyte). Two hours later, they were treated with
progesterone, cultured, and scored for the percentage GVBD. For
both (A) and (B), essentially similar results were obtained in five
other independent experiments.mRNA-injected oocytes than in control oocytes (data not
shown, but note that upon maturation Cdc2 Tyr-15 dephos-







































438 Nakajo et al.phorylation occurs invariably just before GVBD; cf. Gautier
et al., 1989; Ferrell et al., 1991; Jessus et al., 1991; Iwashita
t al., 1998). In these experiments, as in the previous
xperiments (cf. Fig. 3A), DC-Chk and DA-Chk proteins
ere synthesized in oocytes at comparable levels and in 10-
o 15-fold excess over endogenous XeChk1. Thus, signifi-
antly, overexpression of a dominant-negative Chk1 mu-
ant (and hence inhibition of endogenous Chk1) in imma-
ure oocytes facilitated the release from prophase I arrest by
rogesterone. We obtained essentially the same results with
verexpression of a C-terminal half (amino acids 264–472)
f XeChk1 (termed DN-Chk; see Fig. 1A), suggesting that
he C-terminal half was the (regulatory) domain whose
verexpression acted in a dominant-negative manner (see
iscussion).
To confirm these interesting results further, we attempted
o inhibit specifically endogenous Chk1 function in another
ay. To this end, we took advantage of affinity-purified,
olyclonal anti-XeChk1 antibody (which was used for West-
rn blot analysis in Fig. 2). When injected into immature
ocytes overexpressing WT-Chk, the anti-XeChk1 antibody
uppressed specifically the maturation-inhibiting activity of
he overexpressed WT-Chk, in a dose-dependent manner (in
he range of 50–300 ng/oocyte), indicating that the antibody
cted as a neutralizing antibody against XeChk1. Hence, to
nhibit endogenous Chk1 function, we injected this anti-
eChk1 antibody (200 ng) into freshly prepared immature
ocytes. Similar to injection of DA-Chk mRNA alone (see
bove), injection of the antibody alone could not release
ocytes from prophase I arrest. Upon progesterone treatment,
owever, these oocytes underwent GVBD 30–45 min earlier
han uninjected control oocytes and those injected with pre-
mmune control antibody (Fig. 4B). Thus, inhibition of endog-
nous Chk1 by neutralizing antibody, like inhibition by
ominant-negative Chk1 mutants, facilitated the release from
rophase I arrest in progesterone-treated oocytes. These re-
ults were very reproducible (see the legend of Fig. 4) and,
ogether with the ability of overexpressed wild-type Chk1 to
nhibit maturation or prophase I release (Fig. 3A), suggest
trongly that endogenous Chk1 is involved in prophase I arrest
f oocytes.
Constitutive Inhibition of Cdc25C by Chk1 during
Prophase I Arrest
Although Chk1 was almost certainly involved in
prophase I arrest of immature oocytes, its inhibition alone
(or without progesterone stimulation) was not sufficient to
release the arrest. This somewhat paradoxical result might
be explained as follows. In immature oocytes arrested in
prophase I, endogenous Cdc25C is inhibited due to the
Ser-287 phosphorylation by endogenous Chk1 (and hence
due to the binding of 14-3-3 proteins or sequestration; Peng
et al., 1997; Nurse, 1997); however, since an inhibition of
Chk1 alone (or a release of Cdc25C from 14-3-3 proteins
alone) cannot activate Cdc25C (cf. Peng et al., 1997; see also
Discussion), immature oocytes remain arrested in prophase
Copyright © 1999 by Academic Press. All rightI (with Tyr-15-phosphorylated Cdc2) even after the inhibi-
tion of endogenous Chk1. If this were the case, overexpres-
sion of a Chk1-nonphosphorylatable Cdc25C mutant alone
in oocytes would induce Cdc2 Tyr-15 dephosphorylation
and maturation more efficiently than control overexpres-
FIG. 5. Inhibition of Cdc25C by endogenous Chk1 in immature
oocytes. (A) Effect of overexpression of wild-type Cdc25C or a
Chk1-nonphosphorylatable Cdc25C mutant on prophase I arrest
of immature oocytes. Thirty immature oocytes were injected
with mRNA (5 ng/oocyte) encoding either wild-type Cdc25C
(WT-Cdc25; F) or a Chk1-nonphosphorylatable Cdc25C mutant
(SA-Cdc25; E) and then cultured and scored for the percentage
GVBD at the indicated times. (B) Effect of inhibition of endoge-
nous Chk1 function on the GVBD-inducing activity of overex-
pressed WT-Cdc25 or SA-Cdc25. Thirty immature oocytes were
first injected with anti-XeChk1 antibody (a-Chk1; 200 ng/
oocyte) and then 2 h later with mRNA (5 ng/oocyte) encoding
either WT-Cdc25 () or SA-Cdc25 (); 30 control oocytes prein-
jected with preimmune antibody (IgG) were similarly injected
with either WT-Cdc25 mRNA (F) or SA-Cdc25 mRNA (E).
These oocytes were then analyzed as in (A). For both (A) and (B),
essentially similar results were obtained in four other indepen-
dent experiments.sion of wild-type Cdc25C (as was observed earlier in oo-
cytes that overexpressed WT-Chk; cf. Fig. 3B). We tested
s of reproduction in any form reserved.
439Chk1 Kinase in Xenopus Oocytesthis possibility by injecting immature oocytes with mRNA
(5 ng/oocyte) encoding either WT-Cdc25 or a Chk1-
nonphosphorylatable Cdc25C mutant (or SA-Cdc25). De-
spite the same levels of overexpression (as described earlier
for Fig. 3B), SA-Cdc25 could induce Cdc2 Tyr-15 dephos-
phorylation (not shown) and maturation (or GVBD) much
more rapidly and efficiently than WT-Cdc25 (Fig. 5A). [We
observed consistently, however, that much higher overex-
pression of WT-Cdc25 (by injection of .20 ng mRNA per
oocyte) can induce maturation as efficiently as overexpres-
sion of SA-Cdc25; this was probably due, however, to the
limited amount of 14-3-3 proteins in oocytes, as discussed
below.] Thus, these results do suggest that (endogenous)
Cdc25C is inhibited in immature oocytes, most likely due
to the Ser-287 phosphorylation by (endogenous) Chk1.
To test more directly whether Cdc25C inhibition in imma-
ture oocytes was indeed due to the activity of endogenous
Chk1, finally we injected WT-Cdc25 mRNA or SA-Cdc25
mRNA (5 ng each) into oocytes that were preinjected with
either neutralizing anti-XeChk1 antibody or preimmune con-
trol antibody (200 ng/oocyte each). Injection of SA-Cdc25
mRNA induced GVBD very rapidly (and essentially with the
same kinetics) in both anti-XeChk1 antibody- and control
antibody-injected oocytes (Fig. 5B), indicating that endoge-
nous Chk1 did not influence SA-Cdc25 activity. By contrast,
while injection of WT-Cdc25 mRNA induced GVBD only
inefficiently in control antibody-injected oocytes (as in
antibody-uninjected oocytes; see above), it did induce matu-
ration very rapidly and efficiently in anti-XeChk1 antibody-
injected oocytes, with the GVBD kinetics being rather similar
(if not identical) to that with SA-Cdc25 mRNA injection (Fig.
5B). We obtained essentially the same results with oocytes
that were preinjected with another, independently raised
anti-XeChk1 antibody (data not shown). Thus, without endog-
enous Chk1 function, wild-type Cdc25C had a strong
maturation-inducing activity, close to that of the Chk1-
nonphosphorylatable Cdc25C mutant. These results strongly
suggest that endogenous Chk1 directly acts on and inhibits
(endogenous) Cdc25C in immature oocytes. Taken together,
the present results strongly argue that Chk1 functions consti-
tutively in immature oocytes to inhibit Cdc25C, thereby
contributing to prophase I arrest of the oocytes.
DISCUSSION
In this work, we have cloned the Xenopus homolog of
Chk1, determined its developmental expression, and exam-
ined its role in prophase I arrest of immature oocytes. Our
results show that Chk1, originally identified as a DNA
damage G2 checkpoint kinase in S. pombe (Walworth et al.,
1993), is involved in physiological prophase I (or G2) arrest
of Xenopus oocytes. Moreover, we show that Chk1 function
in oocytes is accomplished via a direct inhibition of
Cdc25C, a mitotic inducer in vertebrate cells (Millar and
Russell, 1992).
Copyright © 1999 by Academic Press. All rightStructure and Biological Activity of Xenopus Chk1
The Xenopus homolog of Chk1, termed XeChk1, has
overall 77 and 28% sequence identity to human and S.
pombe Chk1 kinases, respectively (Fig. 1), and is expressed
at approximately constant levels throughout oocyte matu-
ration and early embryogenesis (Fig. 2). Sequence compari-
son reveals that XeChk1 consists of at least two domains,
an evolutionarily well-conserved N-terminal half (or the
kinase domain) and a less well-conserved C-terminal half
(Fig. 1). When overexpressed, XeChk1 prevented immature
oocytes from maturing upon progesterone treatment; these
cells remained arrested in prophase I (or G2 phase) with
high levels of Cdc2 Tyr-15 phosphorylation (Fig. 3A; and see
Results). Thus, the biological activity of (overexpressed)
XeChk1 is consistent with XeChk1 being a G2 checkpoint
kinase. Overexpression of Chk1 has also been shown to
induce G2 arrest in S. pombe (Walworth et al., 1993;
Walworth and Bernards, 1996), but not in human cells for
an as yet unknown reason (Sanchez et al., 1997).
When overexpressed in oocytes (in greater than 10-fold
excess over endogenous XeChk1), the C-terminal half (DN-
Chk), but not the N-terminal one-third (DC-Chk), of Xe-
Chk1 acted in a dominant-negative manner (see Results),
just like the kinase-deficient, full-length mutant of XeChk1
(DA-Chk). These results suggest that the less well-
conserved C-terminal half is a regulatory domain and may
interact with some cellular component(s) to accomplish the
Chk1 function. The C-terminal half of Chk1 has several
short stretches of amino acids that are well-conserved (Fig.
1B), and one or more of them may be responsible for the
interaction with another protein(s) (cf. Sanchez et al., 1997).
The Chk1/Cdc25C/14-3-3 Protein Pathway
in Oocytes
In both S. pombe and mammalian cells, the DNA
damage/replication G2 checkpoint activates Rad3 (ATM/
ATR proteins in mammals), which in turn probably phos-
phorylates and activates Chk1 (see Nurse, 1997); activated
Chk1 then phosphorylates directly (human) Cdc25C on
Ser-216 (Sanchez et al., 1997). 14-3-3 proteins, or human
homologs of other S. pombe G2 checkpoint gene products
Rad 24/25 (Ford et al., 1994), bind to the Chk1-
phosphorylated Cdc25C (Peng et al., 1997); this binding
does not inhibit greatly the Cdc25C phosphatase activity
per se (cf. Kumagai et al., 1998a), but, instead, appears to act
to sequester Cdc25C in some nonactivatable form (Peng et
al., 1997; Nurse, 1997). In the present study, overexpression
in oocytes of a Chk1-nonphosphorylatable Ser-287 3 Ala
mutant of Xenopus Cdc25C (SA-Cdc25) was able to over-
ride prophase I arrest by overexpressed XeChk1, much more
efficiently than overexpression of wild-type Cdc25C (Fig.
3B). SA-Cdc25, unlike wild-type Cdc25C, has recently been
shown to be unable to bind 14-3-3 proteins in Xenopus egg
extracts (Kumagai et al., 1998a). Thus, it appears very likely
that Chk1 can directly phosphorylate Cdc25C (on Ser-287)
and inhibit its function (via the binding of 14-3-3 proteins)




































440 Nakajo et al.in Xenopus oocytes. These results strongly suggest that the
Chk1/Cdc25C/14-3-3 protein pathway can operate in Xeno-
pus oocytes, as also suggested for yeast and mammalian
cells (Furnari et al., 1997; Peng et al., 1997; Sanchez et al.,
1997).
Although not shown in this paper, we observed occa-
sionally that very high overexpression of wild-type
Cdc25C in oocytes (i. e., more than 10-fold expression
over endogenous Cdc25C, by injection of .20 ng WT-
Cdc25 mRNA per oocyte) can override prophase I arrest
by overexpressed XeChk1, as efficiently as overexpres-
sion of SA-Cdc25. Similar results were obtained, but
much more consistently, when the experiments were
performed with oocytes that did not overexpress Chk1
(and hence expressed only endogenous Chk1) (see Re-
sults). These observations, however, probably occurred
because the oocyte is equipped with only a limited
amount of 14-3-3 proteins (a fivefold molar excess over
endogenous Cdc25C; Kumagai et al., 1998a), and hence
he overexpressed, excess wild-type Cdc25C, which
hould be free even if phosphorylated by Chk1, would
ave an activity similar to that of overexpressed SA-
dc25. In this study, therefore, we routinely employed
oderate overexpression of wild-type Cdc25C or SA-
dc25 (i.e., several-fold expression over endogenous
dc25C, by injection of 5 ng mRNA per oocyte; see
esults), to discriminate clearly between their prophase I
rrest-overriding effects.
Involvement of the Chk1/Cdc25C Pathway in
Prophase I Arrest of Oocytes
Arrest of immature oocytes in prophase I (or the late G2
phase) is universal in the animal kingdom (Sagata, 1996)
and seems to involve many factors (see Introduction). In
Xenopus, a member of the Ste20/PAK family of protein
kinases, has also been implicated recently in prophase I
arrest of oocytes (Faure et al., 1997). We showed here that
inhibition of endogenous Chk1 alone either by overex-
pression of dominant-negative Chk1 mutants or by injec-
tion of neutralizing anti-XeChk1 antibodies has no ap-
preciable effect on prophase I arrest of oocytes, but, upon
progesterone stimulation of the oocytes, it can facilitate
Cdc2 Tyr-15 dephosphorylation and maturation or a
release from prophase I arrest (Fig. 4). Release from
prophase I arrest requires activation of Cdc25C (cf. Gau-
tier et al., 1991), which is induced only by progesterone
signaling, presumably via such kinases as polo-like ki-
nase Plx1 (Kumagai and Dunphy, 1996) and Cdc2 kinase
(Hoffmann et al., 1993). Therefore, our results would
suggest that, although Chk1 inhibition alone is not
sufficient for activation of Cdc25C (consistent with the
mode of Cdc25C inhibition by Chk1 or sequestration of
Cdc25C via the binding of 14-3-3 proteins; see above), it
can facilitate activation of Cdc25C upon progesterone
signaling (probably because it must have made Cdc25C a
readily activatable form or a form freed of 14-3-3 pro-
n
p
Copyright © 1999 by Academic Press. All righteins). If so, it may follow that Chk1 functions constitu-
ively in immature oocytes to inhibit Cdc25C until
his phosphatase undergoes activation by progesterone
ignaling. In strong support of this idea, we indeed
howed that overexpression in oocytes of a Chk1-
onphosphorylatable Cdc25 mutant (SA-Cdc25) alone
an induce Tyr-15 dephosphorylation and maturation
uch more efficiently than overexpression of wild-type
dc25C (Fig. 5A). More specifically, we demonstrated
hat, in oocytes lacking endogenous Chk1 function, even
verexpression of wild-type Cdc25C can induce matura-
ion very efficiently, if not fully comparably to overex-
ression of SA-Cdc25 (Fig. 5B). (The small but significant
ifference in the activities of WT-Cdc25 and SA-Cdc25
ven in the absence of Chk1 function might be due to the
resence of yet another Ser-287-specific kinase in oo-
ytes; see below). Thus, it appears certain that Chk1
irectly acts on and inhibits Cdc25C in immature oo-
ytes, to ensure prophase I arrest of the oocytes until the
ocytes meet with the maturation inducer or progester-
ne (Fig. 6).
Chk1 is present in oocytes throughout maturation (Fig.
A), yet Cdc25C is activated by other kinases during this
eriod. Then, how might the Chk1/Cdc25C pathway be
egulated during maturation? In particular, how might
dc25C be activated in the presence of Chk1? For Cdc25C
o be initially activated in progesterone signaling, it may
FIG. 6. Model for mechanisms of prophase I arrest and release in
Xenopus oocytes. Probable pathways for prophase I arrest are
shown by solid lines, while potential pathways for release from
prophase I arrest are indicated by dashed lines. The upstream
regulator or signal for Chk1 is not known. See text for details. PG,
progesterone; PPase, protein phosphatase. Though not shown here,
Cds1-like kinase might also function to inhibit Cdc25C in imma-
ture oocytes.eed first to be dephosphorylated on Ser-287 (a Chk1
hosphorylation site) and to be freed of 14-3-3 proteins;

















441Chk1 Kinase in Xenopus OocytesCdc25C would only then be activated by other
progesterone-stimulated kinases such as Plx1 (Kumagai and
Dunphy, 1996; Qian et al., 1998). Dephosphorylation of
Ser-287, if it occurs, could be caused, in principle, by either
inactivation of Chk1 or activation of some Chk1-
antagonizing phosphatase, either pathway being elicited
early in progesterone signaling (see Fig. 6). (If so, overex-
pression of Chk1 in oocytes should overcome this Ser-287
dephosphorylation step and, as shown in this study, would
maintain prophase I arrest even after progesterone stimula-
tion, while prior inhibition of Chk1 should cause this step
prematurely and, as also shown here, would facilitate
prophase I release by progesterone.) Besides activation of
Cdc25C, progesterone signaling may also induce inactiva-
tion of the Cdc25C-antagonizing Wee1/Myt1 kinases, per-
haps via such kinases as Mos/MAPK and Cdc2 (cf. Mueller
et al., 1995b; Abrieu et al., 1997; Palmer et al., 1998), to
reinforce the positive feedback loop between Cdc2 and
Cdc25C (Hoffmann et al., 1993; Sagata, 1997). (In this
onnection, the strong Wee1/Myt1 kinase activity in im-
ature oocytes would explain in part why Chk1 inhibition
lone cannot release oocytes from prophase I arrest.) Fi-
ally, for the persistent activation of Cdc25C during matu-
ation (Izumi et al., 1992), Chk1 might be kept inactivated
uring this period, possibly by the feedback control from
ctivated Cdc2 (note that Ser-216 of human Cdc25C, a
hk1 phosphorylation site, is not phosphorylated in M
hase cells; Sanchez et al., 1997). In this way, many
athways might function to regulate the Chk1/Cdc25C
athway, upon release from prophase I arrest and during
aturation (Fig. 6).
Does Chk1 Act as a “G2 Checkpoint” Kinase
in Oocytes?
We have shown here that Chk1 is involved in prophase I
(or G2) arrest of Xenopus oocytes. In Drosophila, Chk1 has
recently been implicated in the DNA replication G2 check-
point at the midblastula stage (Fogarty et al., 1997; Sibon et
l., 1997); this replication checkpoint is thought to be
licited by a critical threshold level of the nucleocytoplas-
ic ratio that is reached at this stage of development
Newport and Kirschner, 1982; Edgar et al., 1986; Dasso and
Newport, 1990). In mice, on the other hand, Chk1 has been
shown to localize to meiotic chromosomes in late zygotene
and pachytene spermatocytes (Flaggs et al., 1997); this
localization has been assumed to mediate the DNA damage
G2 checkpoint control that may operate to repair DNA
breaks that occur naturally for meiotic recombination in
the zygotene/pachytene stages (Hawley and Arbel, 1993;
Lydall et al., 1996). In contrast with these, it is uncertain
whether Chk1 acts as a “G2 checkpoint” kinase in
prophase-I-arrested Xenopus oocytes, since, in these (G2-
arrested) cells, there has been no evidence, in a strict sense,
for the presence of authentic G2 checkpoint control (cf.
Hartwell and Weinert, 1989; Murray and Hunt, 1993).
Indeed, Xenopus oocytes, like oocytes of many other spe-
Copyright © 1999 by Academic Press. All rightcies, complete both DNA replication and meiotic recombi-
nation long before their arrest at prophase I (or, more
strictly, at the diplotene stage) (Dumont, 1972; Benbow,
1985), and their nucleus(DNA)–cytoplasm ratio is ex-
tremely low (Schuetz, 1985). Formally, therefore, neither
the ordinary DNA replication G2 checkpoint nor the DNA
damage G2 checkpoint might operate for prophase I arrest
of oocytes (cf. Newport and Dasso, 1989; Dasso and New-
port, 1990). Despite these considerations, however, it has
been observed that significant repair synthesis of genomic
DNA occurs in prophase-I-arrested Xenopus oocytes (al-
though its physiological significance is not known) (Furuno
et al., 1994). Thus, if this observation were to represent the
existence of G2 checkpoint control in Xenopus oocytes,
then Chk1 might function as a DNA damage G2 check-
point kinase in these cells.
In human cells, Ser-216 of Cdc25C has been shown to
be phosphorylated throughout interphase (G1, S, and G2
phases) (Sanchez et al., 1997), raising the possibility that
Chk1 might function not only as a G2 checkpoint kinase
but also as an ordinary cell cycle regulator (of Cdc25C). (If
so, upon DNA damage or incomplete DNA replication,
Chk1 might function as a G2 checkpoint kinase to
maintain the interphase phosphorylation of Cdc25C un-
til DNA repair/replication is completed; cf. Nurse, 1997.)
More recently, another protein kinase or C-TAK1 has
been implicated in the interphase phosphorylation of
Cdc25C Ser-216; however, a possible involvement of
Chk1 in this phosphorylation has not been eliminated
(Peng et al., 1998). Thus, formally, it would be possible
that Xenopus Chk1 acts as an ordinary cell cycle regula-
tor in prophase I arrest of oocytes (in this case, Chk1
activity might be regulated by some common G2/
interphase regulator). When acting as a G2 checkpoint
kinase in eukaryotic cells, Chk1 is probably regulated by
the upstream kinase Rad3 (ATM/ATR proteins in hu-
mans) that is activated by the DNA damage/replication
G2 checkpoint (cf. Nurse, 1997). Hence, to clarify
whether Chk1 acts as a G2 checkpoint kinase or as an
ordinary cell cycle regulator in prophase-I-arrested oo-
cytes, it will be important to determine the upstream
regulator or signal for Chk1 in these cells (Fig. 6).
After completion of this paper, we learned that another
independently isolated Xenopus Chk1 (essentially the same
as XeChk1 in this paper) can phosphorylate Cdc25C on
Ser-287 in vitro and functions, together with yet another
Ser-287-specific kinase, for the DNA damage/replication
checkpoint in cell-free egg extracts (Kumagai et al., 1998b).
We also learned that Cds1, another G2 checkpoint kinase in
S. pombe, phosphorylates Cdc25 on the same serine resi-
due(s) as Chk1 does (Zeng et al., 1998). Hence, another
Ser-287-specific kinase, possibly Cds1-like kinase, might
also contribute to prophase I arrest of Xenopus oocytes (as
partly inferred from the result of Fig. 5B).
In conclusion, we have shown for the first time that Chk1
is involved in physiological prophase I arrest of Xenopus
oocytes. This finding is very important because it repre-
s of reproduction in any form reserved.
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442 Nakajo et al.sents a novel Chk1 function in development and may open
a new perspective on the range of Chk1 function in multi-
cellular organisms. Further analyses of Chk1 function in
Xenopus oocytes and embryos will surely help us under-
stand better cell cycle regulation in development.
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